𝔖 Bobbio Scriptorium
✦   LIBER   ✦

P-304 5-azacytidine in the treatment of Greek patients with higher-risk myelodysplastic syndromes. An overview

✍ Scribed by Zervakis, K.; Diamantopoulos, P.; Papadopoulou, V.; Iliakis, T.; Mpakarakos, P.; Kalala, F.; Giannakopoulou, N.; Rougkala, N.; Galanopoulos, A.; Variami, E.; Dimitrakopoulou, A.; Viniou, N.

Book ID
123479768
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
67 KB
Volume
37
Category
Article
ISSN
0145-2126

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A randomized study of 2 dose levels of i
A randomized study of 2 dose levels of intravenous clofarabine in the treatment of patients with higher-risk myelodysplastic syndrome
✍ Stefan Faderl; Guillermo Garcia-Manero; Elias Jabbour; Farhad Ravandi; Gautam Bo πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 181 KB πŸ‘ 1 views

## Abstract ## BACKGROUND: Clofarabine is a nucleoside analog with activity in myeloid malignancies. Experience in myelodysplastic syndrome (MDS) is limited. ## METHODS: The goal of this study was to evaluate the activity and safety of 2 different doses (15 mg/m^2^ vs 30 mg/m^2^ daily Γ— 5 days)